Smallest tools could give biggest results in bone repair

February 6, 2012, University of Wisconsin-Madison

When William Murphy works with some of the most powerful tools in biology, he thinks about making tools that can fit together. These constructions sound a bit like socket wrenches, which can be assembled to turn a half-inch nut in tight quarters, or to loosen a rusted-tight one-inch bolt using a very persuasive lever.

The tools used by Murphy, an associate professor of biomedical engineering and orthopedics and rehabilitation at University of Wisconsin-Madison, however, are proteins, which are vastly more flexible than socket wrenches -- and roughly 100 million times smaller. One end of his modular tool may connect to bone, while the other end may stimulate the growth of bone, blood vessels or cartilage.

On February 4th and 6th, at the Society meeting in San Francisco, Darilis Suarez-Gonzalez and Jae Sung Lee of the Murphy lab are reporting that "dip-coated" with modular can stimulate bone and in sheep.

For many years, medical scientists have been fascinated by growth factors -- proteins that can stimulate tissues to grow. But these factors can be too effective or not specific enough, leading to cancer rather than the controlled growth needed for healing.

Murphy wants to start applying the manifold benefits of the modular approach to healing or regenerating bone, tendon, and ligaments, and in particular to replacement surgery after an artificial joint has loosened or failed. Temporarily stimulating bones to grow by placing growth factors near the new implant could shorten and ensure a good, tight fit.

The approach could also be used for reattaching ligaments to bone after sports injuries and healing large bone defects during spinal fusion, or trauma. In this work, Murphy collaborates with two associate professors of orthopedics and rehabilitation at the School of Medicine and Public Health. "Ben Graf focuses on in ," he says, "and David Goodspeed, a lieutenant colonel in the Army who has seen blast injuries during multiple tours in Iraq, is working on the kind of major traumatic wound we think is potentially treatable using this approach."

The working end of the modular structure may feature a fragment of a growth factor, but not the entire protein. "Often, you just want the specific regions that activate the signaling pathways, because that can reduce the chances of stimulating unwanted growth, even cancer," he says.

At the other end, Murphy may place an anchoring molecule that binds to the bone and prevents the modular structure from migrating away from the wound.

With the modular approach, he says, "you might be able to stimulate bone formation without the side effects. We are trying to decrease stimulation outside of the bone defect, trying to design these molecules to specifically generate new bone in a defect, and to stay there."

Animal tests, performed in collaboration with Mark Markel, a professor of veterinary medicine, have shown that the bone is denser around the implant, and that the union between the implant and the bone is stronger than produced by state-of-the-art orthopedic techniques. The added growth factors have not been detected elsewhere in the animal, Murphy says.

Engineering each section of the molecule separately allows their properties to be tailored as needed. "We can take similar protein structures and modulate them," Murphy says. "If we want a molecule that binds very strongly to the surface of a graft, we can do that. If we want one that releases over controllable time-frames, we can do that as well."

Moving from the lab to the clinic is a major step, and Murphy knows that many hurdles remain. "We have shown that this can work in a large, clinically relevant animal model, but realistically, I don't see this being used in the clinic within the next five years."

Murphy says his approach is inspired by biology without trying to exactly duplicate normal communication between cells and tissues. "We are not interested in specifically mimicking a particular structure or function, but nature uses a variety of fundamental mechanisms during development and regeneration, and we are taking lessons from them and designing synthetic systems to achieve similar outcomes. We are not repeating nature, but we are inspired by nature."

Explore further: It's all in the wrapping: Mimicking periosteum to heal traumatic bone injury

Related Stories

It's all in the wrapping: Mimicking periosteum to heal traumatic bone injury

December 13, 2011
A manmade package filled with nature's bone-building ingredients delivers the goods over time and space to heal serious bone injuries faster than products currently available, Cleveland researchers have found.

Mechanical stress can help or hinder wound healing depending on time of application

October 24, 2011
A new study demonstrates that mechanical forces affect the growth and remodeling of blood vessels during tissue regeneration and wound healing. The forces diminish or enhance the vascularization process and tissue regeneration ...

Recommended for you

Stem cell researchers develop promising technique to generate new muscle cells in lab

December 12, 2018
To help patients with muscle disorders, scientists at The University of Texas Health Science Center at Houston (UTHealth) have engineered a new stem cell line to study the conversion of stem cells into muscle. Findings appeared ...

Gut hormone increases response to food

December 12, 2018
The holiday season is a hard one for anyone watching their weight. The sights and smells of food are hard to resist. One factor in this hunger response is a hormone found in the stomach that makes us more vulnerable to tasty ...

New mouse model may speed identification of promising muscular dystrophy therapies

December 12, 2018
A Massachusetts General Hospital (MGH) research team has created a new mouse model of a common form of muscular dystrophy with the potential of rapidly distinguishing promising therapeutic drugs from those unlikely to be ...

New insight into stem cell behaviour highlights therapeutic target for cancer treatment

December 12, 2018
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration – a protein called Prominin-1.

Study examines disruption of circadian rhythm as risk factor for diseases

December 11, 2018
USC scientists report that a novel time-keeping mechanism within liver cells that helps sustain key organ tasks can contribute to diseases when its natural rhythm is disrupted.

New light-based technology reveals how cells communicate in human disease

December 11, 2018
Scientists at the University of York have developed a new technique that uses light to understand how cells communicate in human disease.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.